Metabolic profiling of MRI ‐measured liver fat in the UK Biobank
Obesity · 2023-04 · 31 (4) · 1121-1132
DOI: 10.1002/oby.23687 ↗At a glance
Journal article in Obesity, published online on 2023-03-05. Written by Louisa Gnatiuc Friedrichs and 3 co-authors. Institution: Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK. Major MEDLINE topics: Cardiovascular Diseases, Non-alcoholic Fatty Liver Disease. Cited 12 times so far (Crossref); 34 references. The full text is freely available (open access, CC BY 4.0). Funded by: Medical Research Council UK, University of Oxford.
Abstract (original language)
Objective
Liver fat associates with obesity‐related metabolic disturbances and may precede incident diseases. Metabolomic profiles of liver fat in the UK Biobank were investigated.
Methods
Regression models assessed the associations between 180 metabolites and proton density liver fat fraction (PDFF) measured 5 years later through magnetic resonance imaging, as the difference (in SD units) of each log metabolite measure with 1‐SD higher PDFF among those without chronic disease and not taking statins, and by diabetes and cardiovascular diseases.
Results
After accounting for confounders, multiple metabolites were associated positively with liver fat ( p < 0.0001 for 152 traits), particularly extremely large and very large lipoprotein particle concentrations, very low‐density lipoprotein triglycerides, small high‐density lipoprotein particles, glycoprotein acetyls, monounsaturated and saturated fatty acids, and amino acids. Extremely large and large high‐density lipoprotein concentrations had strong inverse associations with liver fat. Associations were broadly comparable among those with versus without vascular metabolic conditions, although negative, rather than positive, associations were observed between intermediate‐density and large low‐density lipoprotein particles among those with BMI ≥25 kg/m 2 , diabetes, or cardiovascular diseases. Metabolite principal components showed a 15% significant improvement in risk prediction for PDFF relative to BMI, which was twice as great (but nonsignificant) compared with conventional high‐density lipoprotein cholesterol and triglycerides.
Conclusions
Hazardous metabolomic profiles are associated with ectopic hepatic fat and are relevant to risk of vascular‐metabolic disease.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.
- MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
ORCID profiles: Louisa Gnatiuc Friedrichs
Funding
- Medical Research Council UK
- University of Oxford
Cite
APA
Gnatiuc Friedrichs, L., Trichia, E., Aguilar-Ramirez, D., & Preiss, D. (2023). Metabolic profiling of MRI ‐measured liver fat in the UK Biobank. Obesity, 31(4), 1121-1132. https://doi.org/10.1002/oby.23687
Vancouver
Gnatiuc Friedrichs L, Trichia E, Aguilar-Ramirez D, Preiss D. Metabolic profiling of MRI ‐measured liver fat in the UK Biobank. Obesity. 2023;31(4):1121-1132. doi:10.1002/oby.23687
BibTeX
@article{GnatiucFriedrichs2023,
author = {Gnatiuc Friedrichs, Louisa and Trichia, Eirini and Aguilar-Ramirez, Diego and Preiss, David},
title = {Metabolic profiling of MRI ‐measured liver fat in the UK Biobank},
journal = {Obesity},
year = {2023},
volume = {31},
number = {4},
pages = {1121--1132},
doi = {10.1002/oby.23687}
}
EUVIMED